Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin
Aging · 2023
DOI: 10.18632/aging.205175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Yuqi Xin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Tongue Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
- Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.
Zitieren
APA
Xin, Y., Jiang, Q., Liu, C., & Qiu, J. (2023). Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin. Aging. https://doi.org/10.18632/aging.205175
Vancouver
Xin Y, Jiang Q, Liu C, Qiu J. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin. Aging. 2023. doi:10.18632/aging.205175
BibTeX
@article{Xin2023,
author = {Xin, Yuqi and Jiang, Qingkun and Liu, Chenshu and Qiu, Jiaxuan},
title = {Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205175}
}
EUVIMED